Health ❯ Healthcare ❯ Pharmaceuticals ❯ Drug Development

Weight Loss Drugs

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity

A $149 starter offer alongside a January U.S. launch positions the daily tablet to broaden access.

Lilly to Launch Late-Stage Trials of Amylin Obesity Drug After 20% Weight Loss in Mid-Stage Study

Lilly’s Orforglipron Pill Hits Phase 3 Goals and Outperforms Oral Semaglutide in Diabetes Study

Novo Nordisk Launches Wegovy Weight-Loss Drug in India

Robinhood Excluded From June S&P 500 Rebalance Despite Doubling in Value